Cloudbased Drug Discovery Platform Market is reaching US$ 4,323.5 Mn at a CAGR of 13.2% end of 2025

Cloudbased Drug Discovery Platform Market 2022

Cloudbased Drug Discovery Platform Market is likely to grow voraciously, i.e. at a CAGR of 13.2% between 2022-2025, reaching US$ 4,323.5 Mn. Augmented and virtual reality are abreast with advanced technologies on a significant count. VR and AR do have loads of potential for offering in the healthcare vertical. The application areas include surgery and training simulation, and patients care and treatment.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11020

According to Persistence Market Research estimations, the global cloud-based drug discovery platform market is projected to be valued at US$ 1,601.1 Mn by the end of 2017 and is expected to reach a market valuation of US$ 4,323.5 Mn by the end of the forecast period in 2025, witnessing a CAGR of 13.2% in terms of value during the forecast period.

Company Profiles:

IBM Corporation
Tata Consultancy Services Limited
SAS Institute Inc.
BioXcel Corporation
Cloud Pharmaceuticals Inc.
WuXi AppTec (Sanghai) Co. Ltd.
Dassault System
Acelot, Inc

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11020

Global Cloud-based Drug Discovery Platform Market: Dynamics

Revenue drivers

Increasing adoption of cloud-based platforms in the healthcare industry to enhance research efficiency
Traction in the adoption of machine learning and artificial intelligence for drug discovery
Regional healthcare companies adopting cloud-based technologies for collaboration with international healthcare market players

Growth challenges

Concerns regarding infrastructure compatibility issues
Issues pertaining to interoperability of applications with devices

Market trends

Upsurge in the implementation of cloud-based platforms in the healthcare sector across the North America region
Rising adoption of cloud-based mobile applications for collaborative drug discovery

Access Full Report@ https://www.persistencemarketresearch.com/checkout/11020

Global Cloud-based Drug Discovery Platform Market: Forecast by End User

The global cloud-based drug discovery platform market is segmented on the basis of end user into Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations, and Others. Pharmaceutical Vendors is expected to be the largest segment in terms of revenue, with a CAGR of 13.4%. Biotech Vendors is the second largest segment in terms of value, estimated to reach a market valuation of US$ 1,247.8 Mn by the end of 2025.

Global Cloud-based Drug Discovery Platform Market: Forecast by Region

Persistence Market Research tracks the performance of the global cloud-based drug discovery platform market across the key regions of North America, Latin America, Europe, Asia Pacific, and MEA. In terms of value, North America is projected to be the most attractive market in the global cloud-based drug discovery platform market during the forecast period. The North America regional market for cloud-based drug discovery platforms is estimated to hold more than 35% value share by the end of the forecast period in 2025. However, the market in APAC is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, the APAC cloud-based drug discovery platform market is expected to expand at a CAGR of 16.7% during the forecast period.

Read Also-

Sleep Service Providers Market - https://www.persistencemarketresearch.com/market-research/sleep-service-providers-market.asp

Hearing Protection Devices Market- https://www.persistencemarketresearch.com/market-research/hearing-protection-devices-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.